In a bid to get support from the Members of the European Parliament (MEPs), the EHPM called for the European Commission to review what was described as the ‘devastating’ impact, the current approach to the Regulation of Generic Health Claims (the Regulation) will have on the industry, and in particular SMEs, and consumer choice.
